Results 251 to 260 of about 27,202 (348)
A schematic illustration of how noble metals can be used to create nanoparticles (NPs) or nanoclusters (NCs). Noble metal NPs, due to their plasmonic properties, enable photothermal therapy and surface‐enhanced Raman scattering (SERS). In contrast, NCs, which lack a plasmonic resonance band, exhibit fluorescence, making them ideal for bioimaging ...
David Esporrín‐Ubieto+3 more
wiley +1 more source
Complications of Ureteral Stenting: A Case of Extrarenal Displacement. [PDF]
Cai Q, Chen B, Hou M, Liang G, Cai H.
europepmc +1 more source
The artesunate nanoplatform selectively targets ECM CAF, functioning as a GTPase inhibitor through disruption of intracellular serine homeostasis. This metabolic intervention effectively suppresses MAPK cascade activity, which consequently inhibits PTT‐induced CAF to ECM CAF differentiation.
Dongdong Zheng+19 more
wiley +1 more source
Kidney failure from kidney stones: an ANZDATA study. [PDF]
Cheikh Hassan H+7 more
europepmc +1 more source
Biomimetic 3D‐printed hydrogel bioadhesives (PTLAs) are designed to address the limitations of existing bioadhesives, offering solutions for challenging tissue adhesion and enhanced healthcare. These PTLAs feature robust wet/underwater tissue adhesion/sealing, superior freeze/pressure and infection resistance, and adaptive self‐healing/gelling capacity,
Qi Wu+4 more
wiley +1 more source
Complications of Encrusted Stents in Recurrent Nephrolithiasis: A Case Report. [PDF]
Lachkar S+4 more
europepmc +1 more source
AIE‐active tetranuclear Ir(III) complex Ir‐4 as a sonosensitizer/sonocatalyst is formulated into a nanoplatform with an H2S donor. Ir‐4@S‐R NPs achieves combined endogenous NIR chemiluminescence imaging, sonodynamic therapy and release of H2S in situ by a bioorthogonal sonocatalytic reaction in vivo, achieving safe thrombolysis and anti‐inflammatory ...
Zihan Wu+11 more
wiley +1 more source
Efficacy and Safety of Tip-Flexible Suctioning Ureteral Access in Renal Stone Treatment. [PDF]
Gao J, Tang J, Shen Y.
europepmc +1 more source